Hawkins Named Chairman of Bioventus Board of Managers.
M2 PHARMA-January 12, 2016-Hawkins Named Chairman of Bioventus Board of Managers
(C)2016 M2 COMMUNICATIONS
- US-based orthobiologic solutions company Bioventus has appointed Bill Hawkins, retired chairman and CEO of Medtronic and currently lead director of Immucor, as its new chairman of the company's board of managers, the company said.
Dan Lemaitre, who has served as chairman since the inception of Bioventus in 2012, has decided to leave the company's board.
From October 2011 to July 2015, Hawkins served as president and CEO of Immucor, a provider of transfusion and transplantation diagnostic products worldwide.
Prior to that, he served as chairman and CEO of Medtronic.
Previously, he served as president and CEO of Novoste Corp. Hawkins has also held senior leadership positions at American Home Products, Johnson and Johnson, Guidant Corp., and Eli Lilly and Co.
Bioventus is an orthobiologics company that offers products designed to help people heal quickly and safely.
The company has two product portfolios for orthobiologics, Bioventus Active Healing Therapies and Bioventus Surgical that make it a specialist in active orthopaedic healing.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Date:||Jan 12, 2016|
|Previous Article:||Respiratory Products Releases Device for Catching a Cough.|
|Next Article:||Garlasco to Manage Europe, Middle East and Africa Region for Cerus.|